132 related articles for article (PubMed ID: 36379756)
1. Association of leucine zipper protein 2 with prognosis and epigenetic modification in patients with renal clear-cell carcinoma.
Shi X; Li L; Feng D; Wei W
Asian J Surg; 2023 May; 46(5):1993-1997. PubMed ID: 36379756
[No Abstract] [Full Text] [Related]
2. MiT family translocation-associated (TFE3 positive) renal cell carcinoma of childhood.
Katiyar R; U Patne SC; Chowdhary S
Indian J Pathol Microbiol; 2018; 61(4):620-622. PubMed ID: 30303168
[No Abstract] [Full Text] [Related]
3. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
4. A unique case of TFEB amplified renal cell carcinoma.
Vormittag-Nocito E; Matrova E
Pathology; 2020 Oct; 52(6):727-729. PubMed ID: 32778342
[No Abstract] [Full Text] [Related]
5. Leucine zipper protein 1 (LUZP1) serves as a prognostic biomarker for patients with renal papillary cell carcinoma.
Chen M; Wang J; Xiao Y
Asian J Surg; 2023 Sep; 46(9):4011-4013. PubMed ID: 37105814
[No Abstract] [Full Text] [Related]
6. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.
Yamada D; Kikuchi S; Williams YN; Sakurai-Yageta M; Masuda M; Maruyama T; Tomita K; Gutmann DH; Kakizoe T; Kitamura T; Kanai Y; Murakami Y
Int J Cancer; 2006 Feb; 118(4):916-23. PubMed ID: 16152585
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of renal epithelial tumors: advances in research and its impact on prognosis and therapy.
Phillips JL; Pavlovich CP; Walther M; Ried T; Linehan WM
Curr Opin Urol; 2001 Sep; 11(5):463-9. PubMed ID: 11493766
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement.
Fall B; Sarr A; Sow Y; Diao B
Afr J Paediatr Surg; 2011; 8(3):317-9. PubMed ID: 22248899
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up.
Antonelli A; Arrighi N; Tardanico R; Balzarini P; Zanotelli T; Corti S; Zani D; Cozzoli A; Cunico SC; Simeone C
Anticancer Res; 2010 Nov; 30(11):4705-9. PubMed ID: 21115928
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic alterations during renal carcinogenesis.
Arai E; Kanai Y
Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
[TBL] [Abstract][Full Text] [Related]
12. [Renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with lymph node metastasis diagnosed after an injury accident: report of a case].
Chen Y; Kang S; Qiu J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):123-4. PubMed ID: 24742576
[No Abstract] [Full Text] [Related]
13. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
[TBL] [Abstract][Full Text] [Related]
14. Tumor enucleation of renal cell carcinoma: operative technique, DNA cytometry results, complications.
Steinbach F; Stöckle M; Riedmiller H; Weingärtner K; Hohenfellner R
Prog Clin Biol Res; 1991; 370():1-7. PubMed ID: 1924437
[No Abstract] [Full Text] [Related]
15. [The molecular pathogenesis and prognosis of renal cell carcinoma].
Serth J
Urologe A; 2007 Sep; 46(9):1168-9. PubMed ID: 17668170
[No Abstract] [Full Text] [Related]
16. Editorial comment.
Russo P
Urology; 2011 Apr; 77(4):847-8. PubMed ID: 21477710
[No Abstract] [Full Text] [Related]
17. A case of PSF-TFE3 gene fusion in Xp11.2 renal cell carcinoma with melanotic features.
Zhan HQ; Chen H; Wang CF; Zhu XZ
Hum Pathol; 2015 Mar; 46(3):476-81. PubMed ID: 25582502
[TBL] [Abstract][Full Text] [Related]
18. De Novo Mutations Contribute to the Development of Clear-Cell Renal-Cell Carcinoma in a 5-Year-Old Girl.
Yang Z; Zhao J; Zhou L; Wang Y; Hao P; Fang Z
Clin Genitourin Cancer; 2018 Jun; 16(3):e553-e556. PubMed ID: 29551584
[No Abstract] [Full Text] [Related]
19. Clear Cell Papillary Renal Cell Carcinoma.
Zhao J; Eyzaguirre E
Arch Pathol Lab Med; 2019 Sep; 143(9):1154-1158. PubMed ID: 30672334
[TBL] [Abstract][Full Text] [Related]
20. The impact of family history on pathological and clinical outcomes in non-syndromic clear cell renal cell carcinoma.
Tollefson MK; Boorjian SA; Lohse CM; Blute ML; Leibovich BC
BJU Int; 2010 Dec; 106(11):1638-42. PubMed ID: 20553256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
